Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer

Published:2012-09-30 Issue:2 Volume:136 Page:407-417
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Tsang Julia Y. S.,Huang Yu-Hua,Luo Ming-Hua,Ni Yun-Bi,Chan Siu-Ki,Lui Philip C. W.,Yu Alex M. C.,Tan Puay Hoon,Tse Gary M.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-012-2271-6.pdf

Reference35 articles.

1. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755–768. doi: 10.1038/nrc2499

2. Croker AK, Allan AL (2008) Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12(2):374–390. doi: 10.1111/j.1582-4934.2007.00211.x

3. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983–3988. doi: 10.1073/pnas.05302911000530291100

4. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H (2006) CD44+/CD24− breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res 8(5):R59. doi: 10.1186/bcr1610

5. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5):555–567. doi: 10.1016/j.stem.2007.08.014

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer;Oncogene;2024-09-09

2. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies;Cancers;2024-07-07

3. Unveiling the vulnerabilities of synthetic lethality in triple-negative breast cancer;Clinical and Translational Oncology;2023-04-20

4. Cancer Stem Cells are Actually Stem Cells with Disordered Differentiation: the Monophyletic Origin of Cancer;Stem Cell Reviews and Reports;2023-01-17

5. Prognosis assessment of CD44+/CD24− in breast cancer patients: a systematic review and meta-analysis;Archives of Gynecology and Obstetrics;2022-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3